Delivery Order SPE2DB22D2009-SPE2DB25FL7YC
Award Date
2/19/25
Potential Completion Date
2/20/25
Potential Value
$3.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Methotrexate 2.5 mg tablets. The contract, valued at $2,294.28, is a firm-fixed-price delivery order with a completion date of July 18, 2024. While there is no set-aside designation, AmerisourceBergen has been awarded numerous federal contracts by the DLA and other agencies, including a $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Methotrexate 2.5 mg tablets. The award, valued at $6,197.51, is a firm fixed-price delivery order contract with a completion date of May 16, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $2,809.19, is for the delivery of Methotrexate 2.5 mg tablets in 100-count bottles. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., which has a $999,999,999 IDC with the DLA Troop Support Medical to provide a...
This federal contract award, valued at $6,032.75, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of Methotrexate 2.5 mg tablets. The contract is a Firm Fixed Price Delivery Order that runs through November 2024. AmerisourceBergen, a major pharmaceutical distributor, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth up to $999,999,999 through November 2026. This IDC serves as a primary vehicle for...
This federal contract award is a delivery order (SPE2DB20D1100|SPE2DB25FY70K) issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $3,174.36 firm-fixed-price contract is for the delivery of Methotrexate 2.5 mg tablets, a medication used to treat various conditions. The contract has an ultimate completion date of October 25, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
The federal contract award is for the delivery of Methotrexate 2.5 mg tablets, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $1,999.68, is a firm fixed price delivery order awarded to AmerisourceBergen Drug Corp, a subsidiary of the parent company Cencora, Inc. (doing business as AmerisourceBergen). This award is associated with a larger indefinite delivery contract (IDC) held by AmerisourceBergen Drug Corp, valued up to...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type, valued at $6,803.95, for the supply of Methotrexate 2.5 mg tablets. The contract has an ultimate completion date of December 4, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,532.30, is a firm fixed-price delivery order for the supply of 4,566,813,741 units of Methotrexate 1 GM vials. The award does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Methotrexate 2.5 mg tablets. The contract has a ceiling value of $9,777.14 and an ultimate completion date of May 1, 2024. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) between the DLA Troop Support Medical and Cencora, Inc., the parent company of AmerisourceBergen Drug Corp. This IDC, valued at up to...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor, for the supply of Methotrexate 2.5 mg tablets. The contract, valued at $2,294.28, is a firm-fixed-price delivery order with an ultimate completion date of August 9, 2024. Amerisourcebergen, through its corporate office division, will provide these pharmaceutical products to support federal healthcare programs and military treatment facilities. This...